Log in to your Inderes Free account to see all free content on this page.
Diamyd Medical
1.05 SEK
+3.33 %
Less than 1K followers
DMYD B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Diamyd Medical
P/E
Median 2019-2025
EV/S
Median 2019-2022
EV/EBIT
Median 2019-2022
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 8.11 | 38.44 | 32.75 | 14.17 | 9.74 | 16.34 | 11.30 |
| Shares | 71.2 | 71.2 | 73.6 | 79.2 | 77.3 | 100.2 | 137.5 |
| Market cap | 577.6 | 2,735.6 | 2,411.9 | 1,121.6 | 753.1 | 1,637.5 | 1,553.7 |
| Enterprise value | 521.6 | 2,668.0 | 2,273.3 | 1,002.6 | - | - | - |
| EV/S | 332.7 | 7,824.2 | 8,985.3 | 2,228.0 | - | - | - |
| EV/EBITDA | neg. | 269.8 | neg. | neg. | - | - | - |
| EV/EBIT | neg. | 274.0 | neg. | neg. | - | - | - |
| P/E | neg. | 281.9 | 40.2 | neg. | neg. | neg. | neg. |
| P/B | 9.20 | 37.74 | 12.74 | 5.23 | 4.07 | 11.22 | 5.55 |
| P/S | 368.3 | 8,022.4 | 9,533.1 | 2,492.4 | 1,369.3 | 12,595.8 | 11,951.9 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 84.6 % | 80.8 % | 94.0 % | 90.6 % | 90.0 % | 67.2 % | 79.4 % |
| Gearing ratio | 1.2 % | 1.1 % | 0.4 % | 0.4 % | 0.4 % | - | - |
Login required
This content is only available for logged in users